000 days 00 hours 00 minutes 00 seconds

We anticipate an event in measure with the monumental feat the industry achieved in collaboration with researchers and public bodies has made to public health globally and to humanity collectively this past year. It is particularly exciting that this landmark year coincides with the Prix Galien Golden Jubilee – celebrating 50 years of innovations that have improved the human condition.


*The Galien Forum and Prix Galien USA Ceremony will take place on October 28, 2021, though in order to ensure the safety of all participants our format may shift in keeping with COVID-19-related guidelines issued by the Centers for Disease Control and Prevention (CDC) and New York City authorities. The Galien Foundation is considering and planning for multiple scenarios, including a smaller in-person event with digital access, a partially virtual event, and a completely virtual event. Updates will be posted and shared with our network via email as soon as they are confirmed.

“…The right event, on the right issue at the right time

— Ban Ki-moon, Secretary-General, United Nations

 

The  Galien Forum, held every autumn at New York’s Alexandria Center for Life Sciences, offers a full day of spirited discussions with Nobel Laureates, top policymakers, and leading industry executives who offer perspectives on the most significant health challenges of our time while highlighting the latest research and clinical pathways toward diagnosis, treatment, and cure.

Time and again, Forum participants praise the caliber of the speakers and their fellow attendees, the quality of the panel discussions and presentations, and the recognition of industry’s critical role in creating life-saving innovations.

Previous Forum Topics & Programs

2020, 2019, 2017, 2016, 2015, 2014, 2013, 2012, 2011, 2010

Previous Forum Reports

2018, 2017, 2016

Previous Forum Speakers

See Candids

Galien Forum 2021 Speakers

Scott Armstrong

Scott Armstrong
Chairman, Pediatric Oncology at Dana-Farber Cancer Institute and President, Dana-Farber/ Boston Children’s Hospital Cancer and Blood Disorders Center

Stephane Bancel, CEO, Moderna

Stephane Bancel
CEO, Moderna

Bar-Zohar

Danny Bar-Zohar
Global Head of Development, Merck Healthcare KGaA

Albert Bourla
Chairman and CEO, Pfizer

Robert Bradway
Chairman & CEO, Amgen

Robert M. Califf

Robert M. Califf
Head of Clinical Policy and Strategy for Verily and Google Health; Adjunct Professor, Duke University and Stanford UniversityFormer FDA Deputy Commissioner to Barack Obama

Sue Desmond-Hellmann

Sue Desmond-Hellmann
Prix Galien USA Committee Chair; Former Chief Executive Officer of the Bill & Melinda Gates Foundation

Mikael Dolsten
Chief Scientific Officer & President, WW Research, Development and Medical, Pfizer

Cristina Durán
Chief Digital Health Officer, R&D, AstraZeneca

Anthony S. Fauci
Director, National Institute of Allergy and Infectious Diseases & Chief Advisor to the President of the United States

Ken Frazier, CEO, Merck & Co.

Ken Frazier
Executive Chairman of the Board of Directors, Merck & Co., Inc.

Laurie Glimcher
President & CEO, Dana-Farber Cancer Institute;
Professor of Medicine, Harvard Medical School

Alex Gorsky, CEO, J&J

Alex Gorsky
Chairman and Board of Directors & CEO, Johnson & Johnson

Ann Graybiel

Ann Graybiel
Institute Professor at MIT, Department of Brain and Cognitive Science

Dan Grossman
Managing Director and Senior PartnerBoston Consulting Group

Sebastian Guth
President, Bayer Pharmaceuticals, Americas Region

Samit Hirawat
Executive Vice President, Chief Medical Officer, Global Drug Development, Bristol Myers Squibb

William G. Kaelin

William Kaelin
Sidney Farber Professor of Medicine, Harvard Medical School and Dana-Farber Cancer Institute

Hon. Patrick J. Kennedy

Hon. Patrick J. Kennedy
Former U.S. Representative (D-RI); Founder, The Kennedy Forum; Former Member, President’s Commission on Combating Drug Addiction and the Opioid Crisis; Co-Founder, One Mind; Co-Founder, Mental Health for US

Michelle Longmire

Michelle Longmire
Co-Founder and CEO, Medable

Crystal L Mackall
Ernest and Amelia Gallo Family Professor of Pediatrics and Medicine, Director, Stanford Center for Cancer Cell Therapy. Director, Parker Institute for Cancer Immunotherapy at Stanford, Associate Director, Stanford Cancer Institute, Stanford University

Joel Marcus
Executive Chairman & Founder, Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments; Co-Founder, Alexandria Summit

Kelsey Martin
Director of the Simons Foundation Autism Research Initiative (SFARI)

Michelle McMurry-Heath
President & CEO, BIO

Michel Pairet

Michel Pairet
Board of Managing Directors – Innovation, Boehringer Ingelheim

Andy Plump

Andy Plump
President, Research & Development, Takeda Pharmaceuticals Company Ltd.

Leonard Schleifer

Leonard Schleifer
CEO, Regeneron

Richard Pops

Richard Pops
Chairman & Chief Executive Officer, Alkermes

MaryAnne Rizk, PhD
Chief Strategy Officer, Medable

Michael Rosenblatt
Co-Chair Galien Forum;
Senior Partner, Flagship Pioneering

Dan_Skovronsky

Daniel M. Skovronsky
President, Lilly Research Laboratories; Chief Scientific & Medical Officer, Eli Lilly and Company

Pascal Soriot
CEO, AstraZeneca

Jeffrey Spaeder

Jeffrey A. Spaeder
Chief Medical and Scientific Officer, and Senior Vice President, IQVIA

Jay Stamatis
Vice President, Head of Business Development and Acquisitions, AbbVie

Julie Sweet

Julie Sweet
CEO & Chair of the Board, Accenture

Marti Taylor

Marti Taylor
President & CEO, OneFifteen

Alexandra Von Plato
CEO, Publicis Health

Michel Vounatsos
Chairman and CEO, Biogen

Lynne Zydowsky
Chief of Science, Alexandria Real Estate Equities, Inc. & Alexandria Venture Investments; President & Co-Founder Alexandria Summit